Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...

By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

An international team led by Monash University researchers has uncovered the genetic code governing the way genetic mutations ...

Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. HARWELL, England — When Wes Streeting, the U.K. health secretary, took ...

The amount of equity flowing into companies developing mRNA-based vaccines has significantly declined so far in 2025, suggesting the financial fallout from policy shifts in the US is starting to take ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving ...